Literature DB >> 2406503

Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy.

B J Cooper1, E A Gallagher, C A Smith, B A Valentine, N J Winand.   

Abstract

The expression of dystrophin was examined immunocytochemically in skeletal and cardiac muscle of canine carriers of X-linked muscular dystrophy, a model of Duchenne muscular dystrophy. In skeletal muscle, the expression of dystrophin was heterogeneous, individual fibers being strongly positive, negative, or intermediate in staining. Some fibers expressed dystrophin discontinuously along their length. Between 4 and 24 weeks of age, the expression of dystrophin in skeletal muscle of carriers became more uniform and the number of negative fibers declined. In the heart dystrophin was also expressed in a mosaic pattern, individual cells being either fully positive or negative by immunocytochemistry. There was no apparent change in the pattern of expression between 12 weeks and 4 years of age. These results indicate that in the mosaic skeletal muscle fibers of carriers dystrophin is initially expressed in a heterogeneous pattern and that, in time, it becomes more uniformly distributed. This change could be explained by recruitment of competent satellite cells or by gradual diffusion of the protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406503

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice.

Authors:  B Weller; G Karpati; S Lehnert; S Carpenter; B Ajdukovic; P Holland
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

2.  Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.

Authors:  K Haginoya; K Yamamoto; K Iinuma; T Yanagisawa; Y Ichinohasama; M Shimmoto; Y Suzuki; K Tada
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

3.  Heterozygotic gene expression in endomyocardial biopsies: a new diagnostic tool confirms the Duchenne carrier status.

Authors:  M Schmidt-Achert; P Fischer; W Müller-Felber; H Mudra; D Pongratz
Journal:  Clin Investig       Date:  1993-03

4.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

Authors:  E Pegoraro; R N Schimke; K Arahata; Y Hayashi; H Stern; H Marks; M R Glasberg; J E Carroll; J W Taber; H B Wessel
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

5.  Renal disease in carrier female dogs with X-linked hereditary nephritis. Implications for female patients with this disease.

Authors:  R Baumal; P Thorner; V E Valli; R McInnes; P Marrano; R Jacobs; A Binnington; A G Bloedow
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed.

Authors:  Bruce F Smith; Yongping Yue; Philip R Woods; Joe N Kornegay; Jin-Hong Shin; Regina R Williams; Dongsheng Duan
Journal:  Lab Invest       Date:  2010-08-16       Impact factor: 5.662

Review 7.  Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.

Authors:  Joe W McGreevy; Chady H Hakim; Mark A McIntosh; Dongsheng Duan
Journal:  Dis Model Mech       Date:  2015-03       Impact factor: 5.758

Review 8.  Multiple Species Comparison of Cardiac Troponin T and Dystrophin: Unravelling the DNA behind Dilated Cardiomyopathy.

Authors:  Jennifer England; Siobhan Loughna; Catrin Sian Rutland
Journal:  J Cardiovasc Dev Dis       Date:  2017-07-07

9.  Canine muscle cell culture and consecutive patch-clamp measurements - a new approach to characterize muscular diseases in dogs.

Authors:  Henning Christian Schenk; Klaus Krampfl; Wolfgang Baumgärtner; Andrea Tipold
Journal:  BMC Vet Res       Date:  2012-11-21       Impact factor: 2.741

Review 10.  Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.

Authors:  Kenji Rowel Q Lim; Narin Sheri; Quynh Nguyen; Toshifumi Yokota
Journal:  Genes (Basel)       Date:  2020-07-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.